Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of Different Parameters on Extubation Time After Cardiac Surgery.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03309280
Recruitment Status : Completed
First Posted : October 13, 2017
Last Update Posted : January 27, 2020
Sponsor:
Information provided by (Responsible Party):
Eric DEFLANDRE, MD, PhD, FCCP, FAHA, Astes

Brief Summary:
The aim of this study is to determine which factors could be at risk of delayed extubation after cardiac surgery.

Condition or disease Intervention/treatment
Thoracic Surgery Other: Duration of intubation Diagnostic Test: Evolution of the renal function

Detailed Description:
The aim of this study is to determine which factors could be at risk of delayed extubation after cardiac surgery. Several parameters of ventilation and infusion were recorded during surgery. A statistical analysis will be performed to determine if one of many of these are significant. The investigator does not assign specific interventions to the study participants, so the present study is observational and not interventional.

Layout table for study information
Study Type : Observational
Actual Enrollment : 132 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Influence of Different Parameters on Extubation Time After Cardiac Surgery.
Actual Study Start Date : October 9, 2017
Actual Primary Completion Date : April 3, 2018
Actual Study Completion Date : June 1, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Surgery

Group/Cohort Intervention/treatment
Patient at risk for OSA scheduled for Cardiac surgery
Patients with a positive STOP-Bang and DES-OSA score (that means patients at risk for OSA)
Other: Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.

Diagnostic Test: Evolution of the renal function
Evolution of the renal function in the next two days

Patient not at risk for OSA scheduled for Cardiac surgery
Patients with a negative STOP-Bang and DES-OSA score (that means patients not at risk for OSA)
Other: Duration of intubation
Time between intubation in the operating room and exhumation in the Intensive Care Unit.

Diagnostic Test: Evolution of the renal function
Evolution of the renal function in the next two days




Primary Outcome Measures :
  1. Time of extubation [ Time Frame: 2 Days ]
    Time when extubation is performed



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
All patients scheduled for cardiac surgery in the Saint-Luc Bouge hospital.
Criteria

Inclusion Criteria:

  • All patients for elective cardiac surgery

Exclusion Criteria:

  • Emergency procedures

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03309280


Locations
Layout table for location information
Belgium
Clinique Saint-Luc de Bouge
Bouge, Namur, Belgium, 5004
Sponsors and Collaborators
Astes
Investigators
Layout table for investigator information
Principal Investigator: Eric Deflandre Astes
Layout table for additonal information
Responsible Party: Eric DEFLANDRE, MD, PhD, FCCP, FAHA, Head of Department, Astes
ClinicalTrials.gov Identifier: NCT03309280    
Other Study ID Numbers: VACC Study
First Posted: October 13, 2017    Key Record Dates
Last Update Posted: January 27, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No